151.58
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf
Täglich
Wöchentlich
Monatlich
7T
30T
60T
YTD
1J
| Datum | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-11-26 | $153.5 | $146.0 | $7.54 | 1,731,976.0 | +5.61% |
| 2025-11-25 | $144.8 | $140.7 | $4.08 | 630,962.0 | +1.61% |
| 2025-11-24 | $143.5 | $139.3 | $4.23 | 1,192,868.0 | -0.41% |
| 2025-11-21 | $144.8 | $139.7 | $5.11 | 967,862.0 | +2.05% |
| 2025-11-20 | $141.1 | $137.8 | $3.24 | 797,928.0 | +0.67% |
| 2025-11-19 | $140.2 | $137.0 | $3.20 | 1,090,996.0 | -0.41% |
| 2025-11-18 | $145.1 | $138.4 | $6.65 | 1,269,412.0 | -3.43% |
| 2025-11-17 | $145.9 | $142.4 | $3.47 | 856,592.0 | -0.90% |
| 2025-11-14 | $146.4 | $143.0 | $3.38 | 642,906.0 | +0.48% |
| 2025-11-13 | $148.8 | $143.9 | $4.93 | 922,514.0 | -1.83% |
| 2025-11-12 | $148.0 | $145.4 | $2.62 | 1,155,771.0 | -0.30% |
| 2025-11-11 | $149.4 | $145.0 | $4.42 | 1,352,557.0 | -1.82% |
| 2025-11-10 | $154.1 | $146.0 | $8.08 | 957,586.0 | -1.54% |
| 2025-11-07 | $154.5 | $149.0 | $5.53 | 1,431,340.0 | -1.57% |
| 2025-11-06 | $155.6 | $152.9 | $2.78 | 944,364.0 | +0.68% |
| 2025-11-05 | $157.7 | $147.7 | $9.97 | 2,937,660.0 | +7.37% |
| 2025-11-04 | $143.9 | $140.8 | $3.05 | 744,398.0 | +0.87% |
| 2025-11-03 | $145.0 | $139.5 | $5.52 | 764,178.0 | -0.87% |
| 2025-10-31 | $143.5 | $137.1 | $6.41 | 1,325,936.0 | +3.75% |
| 2025-10-30 | $140.2 | $136.5 | $3.68 | 898,234.0 | +0.01% |
| 2025-10-29 | $144.3 | $133.6 | $10.69 | 3,007,118.0 | -6.35% |
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf Jahr für Jahr
In dieser detaillierten Analyse präsentieren wir einen umfassenden Überblick über die Kursbewegungen der Neurocrine Biosciences Inc-Aktie im Laufe der Jahre. Durch die Untersuchung der Jahresdaten können Investoren wertvolle Einblicke in die historische Performance und Volatilität der NBIX-Aktien gewinnen. Von bedeutenden Meilensteinen und Schwankungen bis hin zu bemerkenswerten Trends bietet diese gründliche Untersuchung der Preisgeschichte der Neurocrine Biosciences Inc-Aktie eine Grundlage für das Verständnis der Entwicklung der Aktien des Unternehmens im Laufe der Zeit.
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf 2025
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-11 | $157.7 | $137.0 | $20.65 | 22,123,846.0 | +5.84% |
| 2025-10 | $150.0 | $133.6 | $16.37 | 21,451,304.0 | +2.02% |
| 2025-09 | $148.0 | $135.6 | $12.39 | 18,410,355.0 | +0.56% |
| 2025-08 | $140.0 | $123.7 | $16.36 | 17,391,920.0 | +8.87% |
| 2025-07 | $137.4 | $126.2 | $11.29 | 20,229,382.0 | +2.02% |
| 2025-06 | $128.7 | $121.8 | $6.83 | 17,509,187.0 | +2.17% |
| 2025-05 | $130.5 | $105.5 | $25.01 | 32,865,785.0 | +14.24% |
| 2025-04 | $110.9 | $84.23 | $26.66 | 37,381,813.0 | -2.63% |
| 2025-03 | $119.0 | $105.2 | $13.83 | 24,178,404.0 | -6.84% |
| 2025-02 | $153.9 | $113.0 | $40.88 | 31,873,185.0 | -21.80% |
| 2025-01 | $154.6 | $136.1 | $18.48 | 18,531,081.0 | +11.22% |
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf 2024
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2024-12 | $140.0 | $125.2 | $14.79 | 18,782,921.0 | +8.13% |
| 2024-11 | $129.7 | $115.3 | $14.40 | 19,906,873.0 | +5.39% |
| 2024-10 | $131.3 | $111.0 | $20.30 | 19,443,578.0 | +4.38% |
| 2024-09 | $128.8 | $114.1 | $14.73 | 19,963,392.0 | -9.32% |
| 2024-08 | $158.0 | $119.8 | $38.22 | 21,829,501.0 | -10.25% |
| 2024-07 | $150.4 | $135.8 | $14.54 | 15,345,591.0 | +2.83% |
| 2024-06 | $141.5 | $129.3 | $12.16 | 16,164,088.0 | +1.67% |
| 2024-05 | $145.8 | $131.9 | $13.88 | 16,706,330.0 | -1.55% |
| 2024-04 | $145.0 | $130.1 | $14.87 | 16,621,593.0 | -0.28% |
| 2024-03 | $148.4 | $129.2 | $19.22 | 19,907,081.0 | +5.77% |
| 2024-02 | $143.2 | $128.0 | $15.16 | 18,185,535.0 | -6.70% |
| 2024-01 | $143.3 | $129.5 | $13.85 | 15,057,095.0 | +6.08% |
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf 2023
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2023-12 | $133.6 | $115.4 | $18.25 | 16,643,453.0 | +13.01% |
| 2023-11 | $117.5 | $103.6 | $13.89 | 14,627,971.0 | +5.09% |
| 2023-10 | $116.5 | $106.0 | $10.53 | 13,719,886.0 | -1.39% |
| 2023-09 | $119.3 | $108.1 | $11.16 | 14,430,173.0 | +3.32% |
| 2023-08 | $109.9 | $99.98 | $9.94 | 15,712,459.0 | +6.87% |
| 2023-07 | $103.7 | $93.28 | $10.46 | 14,222,291.0 | +8.05% |
| 2023-06 | $99.98 | $89.43 | $10.55 | 16,597,089.0 | +5.33% |
| 2023-05 | $108.0 | $89.04 | $18.94 | 17,981,173.0 | -11.39% |
| 2023-04 | $105.2 | $99.12 | $6.10 | 11,027,326.0 | -0.18% |
| 2023-03 | $103.1 | $92.89 | $10.25 | 16,613,284.0 | -1.82% |
| 2023-02 | $111.1 | $99.77 | $11.33 | 17,405,347.0 | -7.06% |
| 2023-01 | $125.0 | $106.2 | $18.80 | 17,444,124.0 | -7.12% |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):